Artificial Intelligence Fuels Rise of Hard-to-Detect Bots That Now Make up More Than Half of Global Internet Traffic, According to the 2025 Imperva Bad Bot Report
15.4.2025 09:00:00 CEST | Business Wire | Press release
Rise in accessible AI tools significantly lowered the barrier to entry for cyber attackers, enabling them to create and deploy malicious bots at scale For the first time in a decade, automated traffic surpassed human activity, accounting for 51% of all web traffic API-directed attacks surged to 44% of advanced bot traffic, with the travel sector topping the list for bot attacks overall
Thales, the leading global technology and security provider, today announced the release of the 2025 Imperva Bad Bot Report, a global analysis of automated bot traffic across the internet. This year’s report, the 12th annual research study, reveals that generative artificial intelligence (AI) is revolutionizing the development of bots, allowing less sophisticated actors to launch a higher volume of bot attacks with increased frequency. Today’s attackers are also leveraging AI to scrutinize their unsuccessful attempts and refine techniques to evade security measures with heightened efficiency, amidst a growing Bots-As-A-Service (BaaS) ecosystem of commercialized bot services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250415432215/en/
©Thales
Automated bot traffic surpassed human-generated traffic for the first time in a decade, constituting 51% of all web traffic in 2024. This shift is largely attributed to the rise of AI and Large Language Models (LLMs), which have simplified the creation and scaling of bots for malicious purposes. As AI tools become more accessible, cyber criminals are increasingly leveraging these technologies to create and deploy malicious bots which now account for 37% of all internet traffic – a significant increase from 32% in 2023. This is the sixth consecutive year of growth in bad bot activity, posing security challenges for organizations striving to safeguard their digital assets.
Both the Travel and the Retail sectors face an advanced bot problem, with bad bots making up 41% and 59% of their traffic respectively. In 2024, the travel industry became the most attacked sector, accounting for 27% of all bot attacks, up from 21% in 2023. The most notable shift in 2024 is the decline in advanced bot attacks targeting the travel industry (41%, down from 61% in 2023) and the sharp increase in simple bot attacks (52%, up from 34%). This shift indicates that AI-powered automation tools have lowered the barriers to entry for attackers, allowing less sophisticated actors to initiate more basic bot attacks. Rather than relying exclusively on sophisticated techniques, cybercriminals are increasingly utilizing high volumes of simpler bots to inundate travel sites, resulting in more frequent and widespread attacks.
The Rise of AI-Driven Bots: A New Era of Cybersecurity Challenges
The emergence of advanced AI tools, including ChatGPT, ByteSpider Bot, ClaudeBot, Google Gemini, Perplexity AI, and Cohere AI, are transforming not just user interactions but also the methods by which attackers execute cyber threats.According to the Imperva Threat Research team, widely used AI tools are being leveraged for cyberattacks, with ByteSpider Bot alone responsible for 54% of all AI-enabled attacks. Other significant contributors include AppleBot at 26%, ClaudeBot at 13%, and ChatGPT User Bot at 6%.
“The surge in AI-driven bot creation has serious implications for businesses worldwide,” said Tim Chang, General Manager of Application Security at Thales. “As automated traffic accounts for more than half of all web activity, organizations face heightened risks from bad bots, which are becoming more prolific every day.”
As attackers become more adept at utilizing AI, they can execute a variety of cyber threats—ranging from DDoS attacks to custom rules exploitation and API violations. While bot-driven attacks have become increasingly sophisticated, they pose significant challenges for detection efforts.
“This year’s report sheds light on the evolving tactics and techniques utilized by bot attackers. What were once deemed advanced evasion methods have now become standard practice for many malicious bots,” Chang said. “In this rapidly changing environment, businesses must evolve their strategies. It's crucial to adopt an adaptive and proactive approach, leveraging sophisticated bot detection tools and comprehensive cybersecurity management solutions to build a resilient defense against the ever-shifting landscape of bot-related threats.”
Bad Bots Targeting API Business Logic Pose Increased Threat to Modern Enterprises
Recent findings from the Imperva Threat Research team reveal a significant surge in API-directed attacks, with 44% of advanced bot traffic targeting APIs. These attacks aren't just limited to overwhelming API endpoints; rather, they target the intricate business logic that defines how APIs operate. Attackers deploy bots specifically designed to exploit vulnerabilities in API workflows, engaging in automated payment fraud, account hijacking, and data exfiltration.
Analysis in the report reveals a deliberate strategy by cyber attackers to exploit API endpoints that manage sensitive and high-value data. Implications of this trend are especially impactful for industries that rely on APIs for their critical operations and transactions. Financial services, healthcare, and e-commerce sectors are bearing the brunt of these sophisticated bot attacks, making them prime targets for malicious actors seeking to breach sensitive information.
APIs serve as the backbone of modern applications, enabling connectivity across services, streamlining operations, and delivering personalized customer experiences at scale. They underpin essential functions such as payment processing, supply chain management, and AI-driven analytics, making them indispensable for enhancing efficiency, accelerating product development, and unlocking new revenue streams.
“The business logic inherent to APIs is powerful, but it also creates unique vulnerabilities that malicious actors are eager to exploit,” Chang said. “As organizations embrace cloud-based services and microservices architectures, it’s vital to understand that the very features that make APIs essential can also leave them susceptible to risk of fraud and data breaches.”
Financial Services, Healthcare, and E-commerce Industries Face Heightened Risk
The 2025 Imperva Bad Bot Report provides an in-depth analysis highlighting the industries most at risk. Financial services, healthcare, and e-commerce are the most affected sectors, industries that rely on APIs for critical operations and sensitive transactions, making them attractive targets for sophisticated bot attacks.
The financial services sector was the most targeted industry for account takeover (ATO) attacks, accounting for 22% of all incidents, followed by Telecoms and ISPs with 18%, and Computing & IT with 17%. Financial Services has long been a prime target for ATO attacks due to the high value of accounts and the sensitive nature of the data at stake. Banks, credit card companies, and fintech platforms possess vast amounts of Personally Identifiable Information (PII), including credit card and bank account details, which can be profitably sold on the dark web. Additionally, the growing proliferation of APIs within the industry has broadened the attack surface, allowing cyber criminals to exploit vulnerabilities such as weak authentication and authorization methods, thereby facilitating account takeovers and data theft.
About the Research
The 12th Annual Imperva Bad Bot Report is based on insights from our Threat Research and Security Analyst Services (SAS) teams. Our analysis draws from data collected from across the Imperva global network in 2024, including the blocking of 13 trillion bad bot requests across thousands of domains and industries. This dataset provides key insights into bot activity to help organizations understand and address the growing risks of automated attacks.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies for the Defence, Aerospace, and Cyber & Digital sectors. Its portfolio of innovative products and services addresses several major challenges: sovereignty, security, sustainability and inclusion.
The Group invests more than €4 billion per year in Research & Development in key areas, particularly for critical environments, such as Artificial Intelligence, cybersecurity, quantum and cloud technologies.
Thales has more than 83,000 employees in 68 countries. In 2024, the Group generated sales of €20.6 billion.
PLEASE VISIT
Thales Group
Cybersecurity Products
Cybersecurity Solutions
View source version on businesswire.com: https://www.businesswire.com/news/home/20250415432215/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom